Company / Working Capital per Share
Enveric Biosciences, Inc. Working Capital per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$2.73
FY2019
5-year range
-$2.73 / -$0.25
FY2017-FY2019
Trend
-972.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed -973% YoY in FY2019, a notable deviation from the 2-year average annual change of -448%.
Based on SEC 10-K filings.
-2.73 in FY2019.
Declined from $-1.13 to $-2.73 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, working capital per share decreased 972.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$2.73 | -972.7% |
| FY2018 | -$0.25 | +77.5% |
| FY2017 | -$1.13 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026